Amgen Inc's new monoclonal antibody Prolia (denosumab) is the first "biologic therapy" approved by the FDA for the treatment of osteoporosis in menopausal women.
Sylvester O. Agbahiwe, PharmD
Advertisement
Articles by Sylvester O. Agbahiwe, PharmD
Advertisement
Latest Updated Articles
- A Closer Look at New FDA Actions: Amgen's Prolia
August 17th 2010
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis Cases Reach 5100: Investigators Zero In On Lettuce, Possible Taco Bell Link
2
Gedatolisib Combination Approved for PIK3CA Wild-Type HR+, HER2– Breast Cancer
3
Subcutaneous Olanzapine in Schizophrenia: Expanding the Utility of a Proven Therapy
4
Rural Health Transformation Efforts Offer an Opportunity for Pharmacy to Shine
5